Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables Refunds
Ratios

Immunocore Holdings (IMCR) Receivables - Other (2019 - 2022)

Immunocore Holdings (IMCR) has disclosed Receivables - Other for 4 consecutive years, with $9.0 million as the latest value for Q4 2022.

  • Quarterly Receivables - Other rose 354.71% to $9.0 million in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $9.0 million through Dec 2022, up 354.71% year-over-year, with the annual reading at $9.0 million for FY2022, 345.5% up from the prior year.
  • Receivables - Other hit $9.0 million in Q4 2022 for Immunocore Holdings, up from $2.0 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $9.0 million in Q4 2022 to a low of $2.0 million in Q4 2021.
  • Historically, Receivables - Other has averaged $4.5 million across 4 years, with a median of $3.5 million in 2019.
  • Biggest five-year swings in Receivables - Other: plummeted 51.77% in 2020 and later surged 354.71% in 2022.
  • Year by year, Receivables - Other stood at $4.7 million in 2019, then tumbled by 51.77% to $2.3 million in 2020, then decreased by 12.85% to $2.0 million in 2021, then soared by 354.71% to $9.0 million in 2022.
  • Business Quant data shows Receivables - Other for IMCR at $9.0 million in Q4 2022, $2.0 million in Q4 2021, and $2.3 million in Q4 2020.